Period | Date | Adjusted Actuals EPS | GAAP EPS |
---|---|---|---|
Q3 2022 | 2022-10-25 | Future report Set alerts | |
Q2 2022 | 2022-08-03 | 1.26 | 1.26 |
Q1 2022 | 2022-04-27 | 1.30 | 1.30 |
Q4 2021 | 2022-02-16 | 1.15 | 1.15 |
Q3 2021 | 2021-10-27 | 0.89 | 0.89 |
Q2 2021 | 2021-07-28 | 1.01 | 1.01 |
Q1 2021 | 2021-04-28 | 1.07 | 1.07 |
Q4 2020 | 2021-02-17 | 0.67 | 0.67 |
Q3 2020 | 2020-10-28 | 0.00 | 0.00 |
Q2 2020 | 2020-08-04 | 0.29 | 0.20 |
2016-06-14 | Downgrade | Stifel Nicolaus | Buy to Hold | |
2016-04-28 | Reiterated Rating | Avondale Partners | Outperform | $30.00 |
2016-04-27 | Reiterated Rating | RBC Capital | Outperform | $30.00 to $32.00 |
2016-04-27 | Reiterated Rating | Royal Bank Of Canada | Outperform | $30.00 to $32.00 |
2016-04-04 | Boost Price Target | Stifel Nicolaus | Buy | $27.00 to $29.00 |
2016-03-31 | Reiterated Rating | Goldman Sachs | Buy | |
2016-03-31 | Reiterated Rating | Goldman Sachs Group Inc. | Buy | |
2016-03-15 | Initiated Coverage | RBC Capital | Outperform to Outperform | $30.00 |
2016-03-02 | Upgrade | Bank of America | Neutral to Buy | $25.00 to $27.00 |
2016-03-02 | Upgrade | Bank of America Corp. | Neutral to Buy | $25.00 to $27.00 |
2016-02-16 | Lower Price Target | Stifel Nicolaus | $29.00 to $27.00 | |
2016-02-10 | Lower Price Target | Deutsche Bank | Hold | $28.00 to $25.00 |
2016-02-10 | Lower Price Target | Credit Suisse | Outperform | $28.00 to $27.00 |
2016-02-10 | Lower Price Target | Deutsche Bank AG | Hold | $28.00 to $25.00 |
2016-02-10 | Lower Price Target | Credit Suisse Group AG | Outperform | $28.00 to $27.00 |
2016-02-09 | Reiterated Rating | Oppenheimer | Outperform | $36.00 |
2016-02-09 | Reiterated Rating | Oppenheimer Holdings Inc. | Outperform | $36.00 |
2016-02-02 | Reiterated Rating | Barclays | Overweight | |
2016-02-02 | Reiterated Rating | Barclays PLC | Overweight | |
2016-01-19 | Lower Price Target | Barclays | Overweight | $34.00 to $31.00 |
2016-01-14 | Lower Price Target | JPMorgan Chase & Co. | $27.00 to $25.00 | |
2016-01-13 | Lower Price Target | Credit Suisse | $33.00 to $28.00 | |
2016-01-04 | Downgrade | Robert W. Baird | Outperform to Neutral | $35.00 to $28.00 |
2015-12-11 | Lower Price Target | JPMorgan Chase & Co. | $29.00 to $27.00 | |
2015-12-02 | Initiated Coverage | Avondale Partners | Outperform | $34.00 |
2015-11-02 | Lower Price Target | Barclays | Outperform | $40.00 to $38.00 |
2015-10-28 | Boost Price Target | Robert W. Baird | Outperform | $34.00 to $35.00 |
2015-10-28 | Boost Price Target | Barclays | Overweight | $33.00 to $34.00 |
2015-10-27 | Reiterated Rating | Oppenheimer | Buy | $36.00 |
2015-10-15 | Lower Price Target | Robert W. Baird | $34.00 | |
2015-10-09 | Downgrade | JPMorgan Chase & Co. | Overweight to Neutral | $37.00 to $29.00 |
2015-10-02 | Lower Price Target | Credit Suisse | Outperform | $34.00 to $33.00 |
2015-09-24 | Initiated Coverage | Barclays | Overweight | $33.00 |
2015-09-22 | Downgrade | Deutsche Bank | Buy to Hold | $38.00 to $28.00 |
2015-07-29 | Lower Price Target | Susquehanna | Neutral | $31.00 to $30.00 |
2015-07-29 | Lower Price Target | Stifel Nicolaus | Buy | $37.00 to $35.00 |
2015-07-28 | Reiterated Rating | Oppenheimer | Outperform | $36.00 |
2015-06-05 | Reiterated Rating | Longbow Research | Buy | |
2015-05-24 | Reiterated Rating | Citigroup Inc. | Hold | $34.00 |
2015-05-22 | Initiated Coverage | Stifel Nicolaus | Buy | $37.00 |
2015-05-04 | Reiterated Rating | Susquehanna | Neutral | $34.00 to $31.00 |
2015-05-04 | Reiterated Rating | Robert W. Baird | Outperform | $38.00 to $37.00 |
2015-05-04 | Reiterated Rating | Maxim Group | Buy | $29.00 to $26.00 |
2015-05-04 | Reiterated Rating | Ladenburg Thalmann | Buy | $25.00 |
2015-04-30 | Lower Price Target | Citigroup Inc. | Neutral | $35.00 to $34.00 |
2015-04-29 | Set Price Target | Barclays | Buy | $37.00 to $36.00 |
2015-04-29 | Lower Price Target | Deutsche Bank | Buy | $41.00 to $38.00 |
2015-04-17 | Set Price Target | Barclays | Buy | $38.00 to $37.00 |
2015-03-30 | Reiterated Rating | Deutsche Bank | Buy | $41.00 |
2015-03-18 | Upgrade | Morgan Stanley | Equal Weight to Overweight | $34.00 to $38.00 |
2015-02-13 | Downgrade | Susquehanna | Positive to Neutral | |
2015-02-11 | Set Price Target | Barclays | Buy | $40.00 to $38.00 |
2015-02-11 | Set Price Target | Credit Suisse | Buy | $39.00 to $37.00 |
2015-02-10 | Reiterated Rating | Oppenheimer | Outperform | $36.00 |
2015-01-08 | Downgrade | Bank of America | Buy to Neutral | $37.00 to $35.00 |
2014-12-15 | Upgrade | Deutsche Bank | Hold to Buy | $33.00 to $41.00 |
2014-12-12 | Initiated | BB&T Capital Mkts | Buy | $40 |
2014-12-12 | Initiated Coverage | BB&T Corp. | Buy | $40.00 to $40.00 |
2014-12-08 | Boost Price Target | Barclays | Overweight | $38.00 to $40.00 |
2014-10-30 | Reiterated Rating | Citigroup Inc. | Neutral | $34.00 to $35.00 |
2014-10-29 | Reiterated Rating | Barclays | Overweight | $35.00 to $38.00 |
2014-10-29 | Reiterated Rating | Credit Suisse | Outperform | $35.00 to $37.00 |
2014-10-20 | Upgrade | Credit Suisse | Neutral to Outperform | $35.00 |
2014-10-13 | Reiterated Rating | Barclays | Overweight | $36.00 to $35.00 |
2014-09-23 | Reiterated Rating | JPMorgan Chase & Co. | Overweight | $37.00 to $38.00 |
2014-09-12 | Initiated Coverage | Susquehanna | Positive | $37.00 |
2014-07-28 | Reiterated Rating | Citigroup Inc. | Neutral | $33.00 to $34.00 |
2014-07-25 | Reiterated Rating | Credit Suisse | Neutral | $35.00 to $36.00 |
2014-07-25 | Reiterated Rating | Barclays | Overweight | $34.00 to $36.00 |
2014-06-25 | Initiated Coverage | William Blair | Outperform | $36.00 |
2014-05-12 | Upgrade | Ned Davis Research | Sell to Neutral | |
2014-04-24 | Reiterated Rating | Credit Suisse | Neutral | $35.00 |
2014-04-21 | Reiterated Rating | Citigroup Inc. | Neutral | $33.00 |
2014-04-21 | Reiterated Rating | Barclays | Overweight | $34.00 |
2014-03-24 | Boost Price Target | Barclays | Overweight | $30.00 to $32.00 |
2014-02-27 | Initiated Coverage | Morgan Stanley | Equal Weight | |
2014-02-20 | Initiated Coverage | Deutsche Bank | Hold | $33.00 |
2014-02-14 | Boost Price Target | Oppenheimer | Outperform | $27.00 to $34.00 |
2014-01-16 | Upgrade | JPMorgan Chase & Co. | Neutral to Overweight | |
2014-01-13 | Boost Price Target | Barclays | Overweight | $26.00 to $30.00 |
2014-01-10 | Initiated Coverage | Longbow Research | Buy | |
2013-12-16 | Upgrade | Bank of America | Neutral to Buy | $27.00 to $32.00 |
2013-10-29 | Boost Price Target | Robert W. Baird | Outperform | $27.00 to $28.00 |
2012-09-05 | Initiated | Oppenheimer | Outperform | $25 |
2016-06-14 | Downgrade | Stifel Nicolaus | Buy to Hold | |
2016-04-28 | Reiterated Rating | Avondale Partners | Outperform | $30.00 |
2016-04-27 | Reiterated Rating | RBC Capital | Outperform | $30.00 to $32.00 |
2016-04-27 | Reiterated Rating | Royal Bank Of Canada | Outperform | $30.00 to $32.00 |
2016-04-04 | Boost Price Target | Stifel Nicolaus | Buy | $27.00 to $29.00 |
There is presents forecasts of rating agencies and recommendations for investors about this ticker
In ALSN 249 funds of 2213 total. Show all
Fund name | Ticker shares |
---|---|
Vanguard Group, Inc | 11.93M |
FMR LLC | 9.18M |
Burgundy Asset Management Ltd. | 5.84M |
HARRIS ASSOCIATES L P | 5.12M |
LSV ASSET MANAGEMENT | 4.54M |
BlackRock Institutional Trust Company, N.A. | 4.11M |
BlackRock Inc. | 3.93M |
Standard Life Investments LTD | 3.68M |
RENAISSANCE TECHNOLOGIES LLC | 3.40M |
LONDON CO OF VIRGINIA | 2.59M |
Numeric Investors LLC | 2.53M |
FIL Ltd | 2.45M |
Boston Partners | 1.87M |
TIAA CREF INVESTMENT MANAGEMENT LLC | 1.78M |
STATE STREET CORP | 1.71M |
Name Relationship | Total Shares | Holding stocks |
---|---|---|
Carlyle Group Management L.L.C. | 3.01% (5321250) | ALSN / AXTA / BKU / CG / COB / COR / FSL / HDS / HMPR / NLSN / SQBG / YRCW / |
ONEX CORP | 3.01% (5321249) | ALSN / SKH / |
Onex Partners GP Inc. | 3.01% (5321249) | ALSN / |
Dewey Lawrence E. Chairman, President & CEO | 0.15% (266328) | ALSN / |
Graziosi David S. Exec VP, CFO and Treasurer | 0.11% (190474) | ALSN / |
Kirk Randall R. VP, Product Engineering | 0.06% (97526) | ALSN / |
Headly Michael G. SVP, Global MSS | 0.03% (54620) | ALSN / |
Parish David L. Sr. VP, Ops and Purchasing | 0.03% (50988) | ALSN / |
Dick Michael SVP, Ops and Purchasing | 0.02% (36151) | ALSN / |
RABAUT THOMAS W | 0.02% (35546) | ALSN / CYT / KAMN / |
STAR JAMES A | 0.02% (34484) | ALSN / CWH / |
Denison David | 0.02% (27722) | ALSN / |
Dyer Edward L. VP, Defense Programs | 0.01% (23509) | ALSN / |
Scroggins Eric C. VP, General Counsel & Secy | 0.01% (20061) | ALSN / |
Dean Sharon L. VP, Quality and Reliability | 0.01% (13406) | ALSN / |
Ledford Gregory S | 0.01% (10649) | ALSN / HDS / |